ランキング価格はじめての方へ
  1. 米国企業
  2. BIMI Holdings Inc.

BIMI Holdings Inc.BIMI

時価総額
$2.2万
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2011年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日
NET LOSS------1,578,415-16,999,794-4,452,279-1,877,925-34,921,745-22,318,056
Depreciation and amortization588,278831,084844,6571998,189944,0121261,98356,041244,116223,561
Impairment loss of Goodwill---------265
Inventories impairment reserve---------93,88459,567
Allowance for doubtful accounts------1520,969146,977-53,6981
Amortization of discount of convertible promissory notes-------104,9752554,2923
Profit/Loss on disposal of discontinuing operations and subsidiaries----------529,320
Accounts receivable--------48,387---1,357,394
Advances to suppliers-----------490,168
Inventories-271,495132-2,074,453-2,746,175-1,055,168-106,440--5
Prepayments and other receivables-----------464,103
Operating lease-right of use assets-393,50329,792-238,756769,446909,360316,621-720,899-93,592-976,3721
Accounts payable, trade--------5-453,7386
Advances from customers-----------970,688
Operating lease liabilities--------45,520915,0041
Taxes payable-----------219,026
Other payables and accrued liabilities357,650-145,39471,11563,311457,2881510,499-1,925590,979-2,617,7651
Net cash used in operating activities from continuing operations-892,708-995,080-2,473,729159,832---1,094,441--1,275,725-10,255,206
Net cash provided by operating activities from discontinued operations--------970,351843,382--
Net cash used in operating activities2-----908,229-343,970-2,064,792-3,517,733-1,275,725-10,255,206
Disposal of Zhuoda----------924,740
Payment for the acquisition of Qiangsheng, Eurasia and Mingkang Hospitals---------3-
Payment for the acquisition of Phenix Bio Inc----------2
Deposit for the acquisition of Cogmer--------3-3,065,181-
Discontinued operations-Disposal of Zhuoda-----------27,117
Discontinue operations-held for sale of Zhongshan, qiangsheng, Eurasia and Mingkang----------311,277
Purchase of property, plant, and equipment38,68296,038218,744204,472191,375---258,961--
Net cash used in investing activities from continuing operations--921,993-341,6342-407,505--116,976-12,424,465-696,517-536,866
Net cash provided by investing activities from discontinued operations-------49,74112--
Net cash (used in) provided by investing activities-3,161,644------166,717-724,465-696,517-536,866
Issuance of common stocks------500,000---5
Net proceeds from issuance of convertible promissory notes--------534,2017-
Repayment of short-term loans----------49,882
Repayment of long-term loans----------486,442
Amount financed from (to) related parties--------148,700-478,1834
Net cash provided by financing activities from continuing operations--2,093,199248,251-45,160--1468
Net cash provided by financing activities from discontinued operations-------819,609---
Net cash provided by investing activities2----1211,2642468
EFFECT OF EXCHANGE RATE ON CASH----------85,681
(DECREASE) INCREASE IN CASH--------133,7085-2,272,795
Cash paid for income tax333,6157,94865,413---117-45,178444,6336,092
Cash paid for interest expense, net of capitalized interest-----353,745388,623-101,417163,883163,326
Issuance of shares of Common stock for the equity acquisition of Chongqing Guanzan Technology Co., Ltd.--------3--
Issuance of shares of Common stock for equity acquisition of Zhongshan Chaohu Hospital---------3-
Issuance of shares of Common stock for equity acquisition of Guoyitang Hospital-------3-4-
Issuance of shares of Common stock for equity acquisition of Zhuoda---------1-
Issuance of shares of Common stock for payment of improvements to offices---------696,896-
Goodwill recognized from equity acquisition of Guoyitang Hospital--------77-
Outstanding payment for equity acquisition of Zhongshan Chaohu Hospital---------5-
Common stock to be issued upon conversion of convertible promissory notes-960,000-2-------
Issuance of common share for equity acquisition of Mali Hospital---------5-